市场调查报告书
商品编码
1399615
马医疗保健市场规模 - 按产品(疫苗、药品、医疗添加剂、诊断)、适应症(寄生虫控制、马脑脊髓炎、马流感)、配销通路、全球预测,2023-2032 年Equine Healthcare Market Size - By Product (Vaccines, Pharmaceuticals, Medical Additives, Diagnostics), Indication (Parasite Control, Equine Encephalomyelitis, Equine Influenza), Distribution Channel, Global Forecast, 2023-2032 |
由于人们越来越重视马匹的预防性医疗保健措施,预计 2023 年至 2032 年马匹医疗保健市场规模将以 6.4% 的CAGR扩大。最近,马主和兽医越来越认识到主动健康管理的重要性,包括疫苗接种计划、寄生虫控制和例行检查。预防措施不仅可以提高马匹的整体健康状况,还可以促进性能优化和寿命延长。向预防性保健方法的转变也反映了对维持马群健康和活力的承诺,推动了对预防性保健产品和服务的需求。
此外,一些产业参与者正在进行大量研发投资,推出新产品和服务,以满足马匹的不同健康需求,从而支持市场成长。例如,2023 年 4 月,Hilltop Bio 推出了创新的马关节健康解决方案 Strydaflex,扩大了其室温再生药物的范围。
马保健品产业分为产品、适应症、配销通路和地区。
从产品来看,由于全球马领域对动物健康和福利的日益重视,疫苗领域的市场份额从 2023 年到 2032 年的CAGR可能为 7.2%。疫苗在预防和控制马匹多种传染病方面日益受到重视。此外,持续的研发工作有助于创造先进和专用的马匹疫苗,以确保全面的保护,从而增加产品需求。
在配销通路方面,电子商务领域的马保健品市场在 2022 年录得可观的销售额,预计 2023 年至 2032 年的CAGR为7%。在线平台可以方便地获取各种马保健品、补充剂、和药物。此外,电子商务网站为马主和兽医专业人士提供了便利,使他们能够在舒适的家中和诊所浏览、比较和购买产品,从而促进该细分市场的成长。
从地区来看,在马术文化日益普及以及该地区对高性能马匹的需求不断增长的推动下,亚太地区马匹保健行业预计将在2023年至2032年间以7%的增长率强劲增长。政府和私营部门对马设施开发的投资激增,提高了人们对马健康的认识。此外,亚洲主要国家赛马、运动、休閒等多元化马术活动的普及将进一步加速区域市场的扩张。
Equine Healthcare Market size is anticipated to expand at 6.4% CAGR from 2023-2032 driven by the growing emphasis on preventive healthcare measures for horses. Of late, horse owners and veterinarians are increasingly recognizing the importance of proactive health management, including vaccination programs, parasite control, and routine check-ups. Preventive measures not only enhance the overall well-being of horses but also boost performance optimization and longevity. The shift towards preventive healthcare approaches also reflects a commitment to maintaining the health and vitality of equine populations, driving the demand for preventive care products and services.
Furthermore, several industry participants are making massive R&D investments to launch new products and services for catering to different health needs of horses, in turn, supporting the market growth. For instance, in April 2023, Hilltop Bio expanded its range of room-temperature regenerative medicines with the launch of Strydaflex, an innovative horse joint health solution.
The equine healthcare industry is segmented into product, indication, distribution channel, and region.
Based on product, the market share from the vaccines segment is likely to witness 7.2% CAGR from 2023-2032 attributed to the rising emphasis on animal health and welfare in the global equine domain. Vaccines are gaining prominence for preventing and controlling numerous infectious diseases among horses. Additionally, the ongoing R&D efforts are contributing to the creation of advanced and specialized equine vaccines for ensuring comprehensive protection, boosting the product demand.
In terms of distribution channel, the equine healthcare market from the e-commerce segment recorded substantial sales in 2022 and is estimated to depict 7% CAGR from 2023 to 2032. Online platforms facilitate easy access to a wide range of equine health products, supplements, and medications. Additionally, e-commerce sites offer convenience for enabling horse owners and veterinary professionals to browse, compare, and purchase products from the comfort of their homes and clinics, thereby contributing to the segment growth.
Regionally, the Asia Pacific equine healthcare industry is set to exhibit robust growth at a 7% growth rate between 2023 and 2032 propelled by the rising popularity of equestrian culture, and the growing demand for high-performance horses in the region. Surging government and private sector investments for the development of equine facilities has led to the higher awareness about horse health. Moreover, the popularity of diverse equine activities, including racing, sports, and leisure across the major Asian countries will further accelerate the regional market expansion.